The World's Greatest Investing Community
Results 121 - 130 of 1076 : Previous 9 10 11 12 13 14 15 16 17 Next
BioSante Investors: It Was Nice While It Lasted
Libigel loses to placebo in two studies, shares down 75% after hours.
Dividend? Buyback? Here's How to Get Both.
But will there be enough to replenish the pipeline?
The New Pfizer: 6 Drug Companies With Bullish Short Trends
Do you agree with short-sellers' optimism for these names?
One analyst's pick for the best place to stash your cash going into the New Year.
Are these stocks ready to take on the market in a rubber match?
A panel of outside experts will help decide Inlyta's fate.
Senators Question Pfizer Lipitor Deals, Ranbaxy Gets FDA Approval for Generic Version
Some senators are concerned that Pfizer's deals with pharmacy benefit managers will undermine the sale of generic versions of Lipitor.
The Easiest Way to Boost Your Income
If you haven't tried covered calls yet, you should give them a closer look.
Results 121 - 130 of 1076 : Previous 9 10 11 12 13 14 15 16 17 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK